{"id":"W2019875881","doi":"10.1016/j.cllc.2012.04.003","title":"A Phase I Open-Label Dose-Escalation Study of Intravenous BI 2536 Together With Pemetrexed in Previously Treated Patients With Non–Small-Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; Boehringer Ingelheim (Canada); Juravinski Cancer Centre","funders":"","keywords":"Pemetrexed; Medicine; Rash; Nausea; Neutropenia; Lung cancer; Adverse effect; Pharmacokinetics; Internal medicine; Phases of clinical research; Oncology; Response Evaluation Criteria in Solid Tumors; Pharmacology; Toxicity; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003378038,0.0003381626,0.0008709744,0.0001486924,0.00008042403,0.00002729856,0.0001900401,0.0001489056,0.0002924219],"category_scores_gemma":[0.00003768018,0.0002198762,0.0000563363,0.0006831106,0.0000953788,0.0002579349,0.00007049303,0.0003250872,0.000003434911],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005686824,"about_ca_system_score_gemma":0.0006140143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00451694,"about_ca_topic_score_gemma":0.004578022,"domain_scores_codex":[0.9975462,0.000155915,0.0008535454,0.0005508651,0.0003821373,0.0005113221],"domain_scores_gemma":[0.9981916,0.0001610975,0.000466594,0.0004921324,0.0003568875,0.0003317033],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004751878,0.03877852,0.9285477,0.0001996804,0.001073293,0.0000149526,0.004078472,0.00007312602,0.00003440313,0.000002162251,0.0004354031,0.02201042],"study_design_scores_gemma":[0.1133864,0.01040192,0.8692917,0.0009247245,0.004127778,0.000001119653,0.000449994,0.0008164833,0.0001076104,9.894527e-7,0.0001561323,0.0003351496],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9896256,0.001742215,0.00005084054,0.0001157866,0.0002732799,0.006993418,0.00007530844,0.00003471335,0.001088862],"genre_scores_gemma":[0.9960698,0.0002366253,0.0004410938,0.0002628372,0.0001940933,0.001542065,0.00009678562,0.00008110816,0.001075597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1086346,"threshold_uncertainty_score":0.8966289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04642812213176898,"score_gpt":0.4313785693585379,"score_spread":0.3849504472267689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}